NexgenRx

NexgenRx EBIT per Share

The EBIT per Share of NexgenRx (NXG.V) as of Nov 1, 2026 is 0.03 CAD. In the previous year, EBIT per Share was 0.02 CAD — a change of 86.49% (higher).

EBIT per Share

0.03CAD

YoY

86.49%

Last updated:

EBIT per Share of NexgenRx is 2025 0.03 CAD. EBIT per Share of NexgenRx was 2024 0.02 CAD. It decreases by 86.49% higher compared to the previous year.

The NexgenRx EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2018
-0.01 CAD
Jan 1, 2019
0.00 CAD
Jan 1, 2020
0.03 CAD
Jan 1, 2021
0.03 CAD
Jan 1, 2022
0.00 CAD
Jan 1, 2023
-0.00 CAD
Jan 1, 2024
0.02 CAD
Jan 1, 2025
0.03 CAD
The NexgenRx EBIT per Share history
YEAREBIT per ShareYoY
0.03CAD+86.49%
0.02CAD-927.60%
-0.00CAD-149.88%
0.00CAD-86.92%
0.03CAD+1.30%
0.03CAD+2,207.84%
0.00CAD-116.98%
-0.01CAD+1.33%
-0.01CAD-190.63%
0.01CAD-275.37%
-0.00CAD-2.91%
-0.01CAD-147.28%
0.01CAD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

NexgenRx Stock analysis

What does NexgenRx do? NexgenRx Inc. is a Canadian company specializing in providing innovative and customer-oriented healthcare solutions. The company was founded in 1999 by Ron Loucks and is headquartered in Ontario. NexgenRx is a leading provider of cloud-based solutions, which help improve the efficiency and quality of healthcare insurance processes. The different business areas of NexgenRx can be divided into three main categories: 1) Health plan administration: NexgenRx serves a wide customer base consisting of companies of all sizes and industries. The company supports employers in offering their employees tailored and cost-effective healthcare benefits. The services include medical and dental care, drug therapies, hospital stays, vision and hearing tests, as well as occupational and disability insurance. 2) eClaims and digital healthcare services: NexgenRx has developed a range of innovative digital healthcare services aimed at making the lives of patients and policyholders easier and more convenient. These include mobile apps for accessing personal health information or an online platform for direct billing. NexgenRx's eClaims solution allows healthcare service providers to directly bill the company, enabling faster processing and less paperwork. 3) Healthcare consulting services: NexgenRx also offers healthcare consulting services. Customers can access the expertise of NexgenRx to assist with healthcare strategy development or the optimization of healthcare plans for their companies. NexgenRx offers a wide range of products and services for its customers, including the Smart Plan, a customizable healthcare program for companies. The company has also developed cloud-based management tools for employers and insurers to effectively manage their healthcare plans. Additionally, NexgenRx provides a modern and simple eClaims system for healthcare service providers, as well as a variety of consulting services aimed at optimizing healthcare plans. In conclusion, NexgenRx Inc. is an innovative company specializing in providing customer-oriented healthcare solutions. The company serves a diverse customer base and offers various products and services, including cloud-based management tools, eClaims systems, and consulting services. Overall, NexgenRx plays a significant role in the healthcare industry by improving the efficiency and quality of insurance processes. NexgenRx is one of the most popular companies on Eulerpool.

Frequently Asked Questions about NexgenRx stock

EBIT per Share of NexgenRx is 0.03 CAD in 2025.

EBIT per Share of NexgenRx changed from 0.02 CAD to 0.03 CAD, representing a 86.49% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share NexgenRx since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — NexgenRx

All Key Metrics — NexgenRx